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Certain strains of Escherichia coli belonging
to different O-(LPS) and H-(flagellar) serotypes
produce potent cytotoxins called Shiga toxins
(Stx) (1). The natural hosts of Shiga toxin-
producing  E. coli (STEC) are farm and wildlife
ruminants. In humans, STEC can cause disease,
although the clinical picture may vary from
uncomplicated diarrhea, to hemorrhagic colitis
(HC), to hemolytic uremic syndrome (HUS) (2,3).
Large outbreaks and cases of HC and HUS in
humans were mainly associated with STEC
strains belonging to serogroup O157. Human
infections with STEC O157 are under nation-
wide surveillance in a number of countries, but
the detection of non-O157 STEC infections is
often limited to a small number of specialized
laboratories because STEC O157 colonies are
more easily detectable on some culture media
than non-O157 STEC types, which are thus often
missed in laboratory diagnosis of stool specimens
(4,5). However, humans are likely more exposed
to non-O157 STEC because these strains are
more prevalent in animals and as contaminants
in foods than STEC O157 (4,6). Infections with
some non-O157 STEC types, such as O26 and
O111, are associated with illness in humans, but
the role of other non-O157 STEC types in human
disease needs further examination (3,7). In
Germany, the number of clinical laboratories
performing diagnosis of STEC from stool samples
has increased since immunologic assays (Stx-
enzyme-linked immunosorbent assay [ELISA])
specific for detection of Stx1 and Stx2 became
commercially available. The Stx-specific ELISA
kits are useful for detection of different serotypes
of STEC; consequently, more non-O157 STEC-
positive stool specimens and bacterial isolates
were sent to our laboratory for confirmation and
typing. In this study, we report on non-O157
STEC infections in 89 human patients infected
during 1996 in Germany. We investigated the
relationship between STEC serotype, STEC
virulence factors (such as the eaeA gene,
production of enterohemolysin), Stx1 and Stx2,
and the clinical signs in the patients.
Isolation of Non-O157 STEC Strains
Of 89 non-O157 STEC isolates from 89
patients, 46 were isolated in the collaborating
laboratories and 43 in our laboratory from stool
samples. STEC isolates or stool specimens were
sent together with patient data (age, gender, and
illness) from 37 private, hospital, and public
health laboratories from rural and urban areas of
Germany. In our laboratory, a small sample of
stool was injected into 5 ml of Tryptic Soy Broth
and incubated overnight at 37°C (8). Aliquots
from the grown stool culture were tested for
toxicity and for Stx-specific DNA sequences by
polymerase-chain reaction (PCR) (9,10). STEC
were isolated from Stx-positive stool cultures by
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combined use of enterohemolysin agar and the
STEC-RPLA test (8). Enterohemolysin-negative
STEC were identified by testing different coliform
colonies with the STEC-RPLA assay. All stool
cultures were additionally plated on Sorbitol
MacConkey Agar (SMAC) for identification of
sorbitol-nonfermenting STEC O157 strains.
Most of our collaborating laboratories in
Germany used Stx-specific ELISA for routine
examination of stool samples. Examination for
STEC was performed in cases of diarrhea, HUS,
or on special request; diagnostic approaches
differed among laboratories. Some supplied only
Stx-ELISA-positive stool specimens for further
examination; others attempted to isolate STEC
colonies by using combinations of commercially
available diagnostic tools such as Stx-ELISA,
STEC-RPLA, agglutinating rabbit antisera for
enteropathogenic  E. coli (EPEC) O-groups
including serogroup O157, enterohemolysin
agar, and SMAC. Of the 37 collaborating
laboratories, two used their own methods, such
as the Stx-toxicity test or an Stx-specific PCR for
identification of STEC from stool.
In our laboratory, all 89 non-O157 STEC
isolates were tested for cytotoxicity by the Stx
test and for production of Stx1 and Stx2 by the
STEC-RPLA assay. The enterohemolytic pheno-
type was determined on enterohemolysin agar
(8). The presence of the eaeA gene was
determined by PCR using two different primer
pairs specific for the conserved region of the eaeA
gene (11,12). Serotyping of O- and H-antigens of
E. coli strains was performed as described (13).
Characterization of Non-O157 STEC
Strains
Only one STEC serotype was isolated from
each of the 89 patients except for one patient
with HC who excreted simultaneously STEC
types O157:H7 and O26:H11. Of the 89 STEC
strains, 69 (77.5%) could be typed to 15 different
O-groups, and 20 were O-untypable or O-rough
(Table 1). The STEC strains varied in H-
antigens, which were conserved within some of
the O-groups, and 31 STEC strains (34.8%) were
nonmotile. Most isolates (n = 59) produced only
Stx1 (66.3%) and 11 (12.4%) only Stx2.
Production of Stx1 and Stx2 was found in 19
(21.3%) strains and was associated with
strains of O-groups 113 and 145. Fifty-four
(60.7%) of the STEC strains were found eaeA-
positive. The eaeA-gene was present in all
STEC strains belonging to some common
serogroups (O26, O103, O111, O118, and O145)
and in 8 of 17 STEC O-rough strains. The
enterohemolytic phenotype was expressed in
82 strains (92.1%) and was highly associated
with eaeA positive STEC (53 [98.2%] of 54 were
positive). All STEC strains were positive for
fermentation of sorbitol.
Relationship Between STEC Types,
Virulence Markers, and Clinical Status of
the Patients
Fifty-one (60.7%) of the patients were
female, and 33 (39.3%) were male; the gender of
five patients was not reported. Of 85 patients
whose ages were known, 46 (54.1%) were 3
months to 6 years of age, 10 (11.8%) were 6 to 15
years of age, and 29 (34.1%) were older than 15
years (Table 2). Patients were divided into four
groups according to case history (Table 1). Six
cases (6.7%) of asymptomatic excretors of STEC
were detected by routine screening of stool
specimens.  Nonbloody diarrhea, in some cases
accompanied with abdominal pain and vomiting,
was reported for 72 (80.9%) patients. Bloody
diarrhea was reported in 7 (7.9%) and HUS in 4
(4.5%) cases. Episodes of protracted, nonbloody
diarrhea for 2 weeks or more were reported for 11
(12.4%) patients. Double infections with STEC
and other diarrheal pathogens were not reported
except for 6 (6.7 %) patients who were additionally
infected with Salmonella enterica sp. (Table 1).
The clinical disease was not associated with
the Stx types produced by the infecting strains.
In contrast, the eaeA-gene was closely associated
with severe illness and young age (Tables 1, 2).
Thus, 9 (81.8%) of the 11 patients with bloody
diarrhea or HUS were infected with eaeA-positive
STEC of serogroups O26, O103, O111, O118, or
O145; 8 (72.7%) of 11 patients with protracted,
nonbloody diarrhea carried eaeA-positive STEC
of serogroups O118, O145, O163, and O-rough. Of
54 patients with eaeA-positive STEC isolates, 41
(75.9%) were younger than 6 years of age with a
peak age of 1 to 3 years (Table 2) and a mean age
of 8 years and 9 months. In contrast, eaeA-
negative STEC were more prevalent in adults
and were isolated from 35 patients; age was
known in 31 (Table 2). Only five (16.1 %) were
younger than 6 years of age, and the mean age in
this group was 27 years and 10 months.
Most of the non-O157 STEC infections
were sporadic, and the sources of infection637 Vol. 4, No. 4, OctoberDecember 1998 Emerging Infectious Diseases
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Table 1. Non-O157 STEC infections in human patients in Germany, 1996
STEC serotypes No. of STEC strains with properties Clinical status
O-groupa Entero- Non-
(no. of Stx1+ hemo- Asympto- bloody Bloody
strains) H-typesb Stx1 Stx2 Stx2 eaeA lytic matic diarrhea diarrhea HUSc
O5 (1) NM   0   0   1   0   1 0   1 0 0
O18 (1) H15   0   0   1   1   1 0   1d 00
O26 (20) H11, NT, NM 16   4   0 20 19 1 17 2d,e 0
O76 (3) H19   3   0   0   0   3 0   3 0 0
O78 (1) NM   0   1   0   0   1 1   0 0 0
O84 (1) NT   1   0   0   1   1 0   1d 00
O91 (4) H14, NM   3   0   1   0   4 0   4 0 0
O103 (7) H2, H7, NT   6   1   0   7   7 0   5d 11
O111 (3) NT   1   1   1   3   3 1   1 0 1
O113 (3) H32, NT   0   0   3   0   3 0   3 0 0
O118 (8) H12, H16 NT   7   1   0   7   7 0   6d 11
O128 (5) H2, NM   3   0   2   0   5 1   4 0 0
O145 (6) H28, NM   1   0   5   6   6 0   5 0 1
O146 (5) H21, H28   3   1   1   0   5 0   4 1d 0
O163 (1) H19   0   1   0   0   1 0   1 0 0
ONT (3) ND   2   0   1   1   3 1   2 0 0
O-rough (17) ND 13   1   3   8 12 1 14 2 0
Total (89) 59 11 19 54 82 6 72 7 4
aONT= O-antigen not typable; O-rough= rough LPS, O-antigen not typable.
bNM= nonmotile; ND= H-antigen not determined; NT= H-antigen not typable.
cHUS= hemolytic uremic syndrome.
dA case of double infection with Salmonella enterica sp.
eA case of a double infection with STEC O26:H11 and O157:H7.
were not identified. However, outbreak
investigations were not routinely performed,
and a number of these infections could be part
of unidentified outbreaks. In four cases, stool
specimens from persons who were in contact
with the patients were examined, and two
outbreaks in families with diarrheal episodes
were detected. One outbreak occurred in a
family living in Berlin; diarrheal symptoms
developed in the parents and their two
children after they returned from vacation on a
farm in Northern Germany. STEC O145:H-
(Stx2 and eaeA positive STEC) could be
isolated from two family members. The second
outbreak was detected in a family living in the
region of Augsburg (Bavaria). The parents had
no diarrheal symptoms, but their children had
diarrhea over a period of 6 weeks. STEC O-
rough, Stx1, and eaeA-positive STEC were
isolated from stool samples of both infants. All
patients from both outbreaks recovered.
Conclusions and Recommendations
Human pathogenicity of E. coli strains
belonging to the STEC group varied according to
serotypes, virulence attributes, and other
unknown factors (7). Besides Shiga toxins, the
eaeA gene product intimin contributed to
diarrheal disease in humans, and typical human
virulent STEC (e.g., enterohemorrhagic E. coli
O157 strains) were found to carry genes for
Shiga toxin(s), intimin, and enterohemolysin (7).
Two major groups of non-O157 STEC strains
were isolated from humans. Group I consisted of
54 strains (60.7%), which were all positive for
eaeA and with one exception for enterohemolysin,
and group II of 35 (39.3%) STEC strains lacking
the eaeA gene. Group I STEC strains were more
frequently associated with severe diarrheal
disease, HUS, and with young age than group II
strains, which were more frequently found in
clinically uncomplicated cases (asymptomatic
carriers, abdominal pain, uncomplicated diar-
rhea) and in older patients. These findings
indicate that some or all of the group II strains
are less virulent or nonpathogenic for humans,
although they can colonize the human intestine.
Many  eaeA-negative non-O157 STEC strains
isolated from healthy animals have been found to
adhere to HEp-2 cells in culture without carrying
DNA sequences specific for diffuse adherence
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E. coli (14). Characterizing the colonization
mechanisms of eaeA-negative STEC could help to
further define their role as human pathogens.
Our finding that infections with eaeA-
positive non-O157 STEC were more frequent in
young infants resembles EPEC infection-related
finding. EPEC cause gastroenteritis in very
young children and occur rarely in adults.
Humans exposed to EPEC show an immune
response against bacterial antigens such as LPS,
intimin, and fimbriae and may thus develop
protective immunity to these pathogens (15).
Similarly, a Canadian study has shown that non-
O157 STEC-infections at young ages may confer
protective immunity to subsequent infections in
humans (16). It is possible that EPEC infections
in early childhood confer cross-reacting protec-
tive immunity against STEC types that share
common antigens (such as LPS and intimin) with
classical EPEC strains. This could explain why
infections with eaeA-positive STEC occur less
frequently in older patients.
Our data support previous findings that non-
O157 STEC types are more frequently involved
in nonbloody diarrhea than STEC-O157, whereas
the latter are more frequently associated with HC
and HUS (7). In 1996, 89 non-O157 STEC and 33
STEC O157 from 121 human patients were
investigated in our laboratory. The proportion of
patients with HUS or HC was 45.5% in the group
of STEC O157 infected compared with 12.4% in
the group of non-O157 STEC-infected patients.
Only one of the 33 STEC O157 strains from
human patients belonged to the sorbitol-
fermenting, ß-glucuronidase-positive type of
O157:H- strains reported in Germany (17).
Humans of all age groups can be infected
with STEC belonging to different serotypes.
Because the association between serotype and
human pathogenicity is not always certain, a
serotype-independent diagnosis of STEC is
required. Although it is not possible for economic
reasons to examine all patients with diarrhea for
STEC, these organisms should be sought in
pediatric patients, who are at higher risk for
serious infection with these pathogens.
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